Logos Global Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$28M	Sell	1,500,000 -250,000	-14%	-$4.14M	1.4%	23
2025 Q4	$23.1M	Buy	+1,750,000	New	+$20.6M	1.39%	26
2025 Q3	–	Sell	-200,000	Closed	-$9.44M	–	67
2025 Q2	$9.44M	Sell	200,000 -150,000	-43%	-$6.11M	1.04%	31
2025 Q1	$13.7M	Buy	+350,000	New	+$15.1M	2.43%	16
2024 Q3	–	Sell	-750,000	Closed	-$33M	–	63
2024 Q2	$33M	Buy	+750,000	New	+$31.8M	2.65%	13
2024 Q1	–	Sell	-150,000	Closed	-$9.06M	–	65
2023 Q4	$9.06M	Buy	+150,000	New	+$7.73M	0.85%	27
2021 Q3	–	Sell	-50,000	Closed	-$518K	–	63
2021 Q2	$518K	Sell	50,000 -150,000	-75%	-$1.52M	0.04%	56
2021 Q1	$2.04M	Hold	200,000	–	–	0.2%	51
2020 Q4	$2.27M	Buy	+200,000	New	+$2.12M	0.19%	50